Japan permits manufacturing, import of Viagra

Japan permits manufacturing, import of Viagra

Leslie Robert Patterson, country manager of Pfizer Pharmaceuticals Inc., meets the press in Tokyo on Jan. 25 after the Tokyo-based affiliate of Pfizer Inc. of the United States obtained permission from Japan's Health and Welfare Ministry to manufacture and import the anti-impotence drug Viagra.

  • Product Code
  • ILEA001078216
  • Registered date
  • 1999/1/25 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 1999 Kyodo News
  • Media size
  • 1864 × 1713 pixel
  • Resolution
  • dpi
  • Deployment size
  • 1.23(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
          Frozen food poisoning

          Frozen food poisoning

          TOKYO, Japan - Toshio Kushiro (far L), president of Maruha Nichiro Holdings Inc., Yutaka Tanabe (2nd from L), president of Maruha Nichiro's subsidiary Aqlifoods Co., and others bow in apology during a news conference in Tokyo on Jan. 25, 2014. An Aqlifoods factory worker was arrested earlier that day over his alleged involvement in the poisoning of Aqlifoods' food products with pesticide that possibly affected the health of more than 2,800 people across the country.
            Frozen food poisoning

            Frozen food poisoning

            TOKYO, Japan - Toshio Kushiro (L), president of Maruha Nichiro Holdings Inc., and Yutaka Tanabe, president of Maruha Nichiro's subsidiary Aqlifoods Co., bow in apology during a news conference in Tokyo on Jan. 25, 2014. An Aqlifoods factory worker was arrested earlier that day over his alleged involvement in the poisoning of Aqlifoods' food products with pesticide that possibly affected the health of more than 2,800 people across the country.
              Novartis Pharma accused over drug ads

              Novartis Pharma accused over drug ads

              TOKYO, Japan - Health, Labor and Welfare Ministry officials hold a press conference at the ministry in Tokyo on Jan. 9, 2014, after filing a criminal complaint with prosecutors against Novartis Pharma K.K. over alleged exaggerated advertising for a blood pressure-lowering drug.
                Mitsubishi Tanabe Pharma ordered to suspend some operations

                Mitsubishi Tanabe Pharma ordered to suspend some operations

                TOKYO, Japan - Mitsubishi Tanabe Pharma Corp. President Michihiro Tsuchiya (L) and Takehiko Fujii (C), president of subsidiary Bipha Corp., apologize in Tokyo on April 13, 2010, after the Health, Labor and Welfare Ministry ordered Mitsubishi Tanabe Pharma to suspend some of its pharmaceutical manufacturing and sales operations for 25 days over the alleged falsification of blood product test data. The subsidiary, which manufactured the product and falsified the data, was ordered to suspend its drug manufacturing business for 30 days. (Kyodo)
                  Comsn to sell nursing-care business after April

                  Comsn to sell nursing-care business after April

                  TOKYO, Japan - Koichi Higuchi (R), president of Comsn Inc., meets with Shinji Asonuma (L), director general of the Health and Welfare Bureau for the Elderly at the Health, Labor and Welfare Ministry in Tokyo on June 13.
                    Japan, U.S. to work to prevent recurrence of banned beef shipmen

                    Japan, U.S. to work to prevent recurrence of banned beef shipmen

                    TOKYO, Japan - J.B. Penn, U.S. undersecretary for farm and foreign agricultural services, speaks at a press conference at the U.S. Embassy in Tokyo on Jan. 24 after a round of talks with Japanese foreign, farm and health ministry officials. Japan and the United States agreed to continue efforts to prevent a recurrence of the Jan. 20 incident in which a risk material for mad cow disease, banned in Japan, was discovered in a shipment of U.S. beef to Tokyo, a Japanese Foreign Ministry official said. (Kyodo)
                      (1)Cow found highly likely to have mad cow disease, 10th in Japan

                      (1)Cow found highly likely to have mad cow disease, 10th in Japan

                      TOKYO, Japan - Two health ministry officials tells a press conference in Tokyo on Feb. 21 that a dairy cow from Kanagawa Prefecture is highly likely to have been infected with mad cow disease. Confirmation is expected when the Ministry of Health, Labor and Welfare hears opinions from experts on Feb. 22 after the case was found in the process of the government-led initiative to test all cows for human consumption for the disease. If confirmed, it would raise the number of cows infected with the disease in Japan to 10.